Biogen Inc. (BIIB) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Biogen financial statements at a glance

Biogen reported revenue of $9.89 billion for fiscal year 2025 (ended December 31, 2025), up 2.2% from fiscal year 2024. Net income was $1.29 billion, a net margin of 13.1%.

At the end of fiscal year 2025 it had total assets of $29.44 billion, total liabilities of $11.18 billion and shareholders' equity of $18.26 billion, with total debt of $6.29 billion.

Its operations brought in $2.20 billion of cash.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

BIIB logo

Biogen Inc.

BIIBUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Revenue
9.89B
Prev Year: 9.68B
YoY: +2.2%
Total Revenue
-
Cost of Revenue
2.38B
Prev Year: 2.21B
YoY: +7.5%
Gross Profit
7.52B
Prev Year: 7.47B
YoY: +0.6%
SG&A Expenses
2.44B
Prev Year: 2.40B
YoY: +1.6%
Operating Expense
-
R&D Expense
1.75B
Prev Year: 2.02B
YoY: -13.0%
Depreciation/Amortization
507.10M
Prev Year: 386.50M
YoY: +31.2%
Net Non Operating Interest Income Expense
-
Interest Exp.(Inc.),Net-Operating, Total
290.20M
Prev Year: 254.40M
YoY: +14.1%
Other Income Expense
-
Other Operating Expenses, Total
24.00M
Prev Year: 12.90M
YoY: +86.0%
Pre-tax Income
-
Operating Expenses
8.17B
Prev Year: 7.43B
YoY: +10.0%
Operating Income
1.72B
Prev Year: 2.25B
YoY: -23.4%
Net Income Common Stockholders
-
Interest Inc.(Exp.),Net-Non-Op., Total
-190.80M
Prev Year: -314.00M
YoY: +39.2%
Diluted NI Available to Com Stockholders
-
Other, Net
24.70M
Prev Year: -29.60M
YoY: +183.4%
Basic EPS
-
Net Income Before Taxes
1.56B
Prev Year: 1.91B
YoY: -18.3%
Diluted EPS
-
Provision for Income Taxes
263.60M
Prev Year: 273.80M
YoY: -3.7%
Weighted Average Shares (basic)
-
Net Income After Taxes
1.29B
Prev Year: 1.63B
YoY: -20.8%
Weighted Average Shares (diluted)
-
Net Income Before Extra. Items
1.29B
Prev Year: 1.63B
YoY: -20.8%
Equity In Affiliates
-
Total Expenses
-
Net Income
1.29B
Prev Year: 1.63B
YoY: -20.8%
Net Income from Continuing and Discontinued Operation
-
Income Available to Com Excl ExtraOrd
1.29B
Prev Year: 1.63B
YoY: -20.8%
Normalized Income
-
Income Available to Com Incl ExtraOrd
1.29B
Prev Year: 1.63B
YoY: -20.8%
Interest Income
-
Diluted Net Income
1.29B
Prev Year: 1.63B
YoY: -20.8%
Interest Expense
-
Diluted Weighted Average Shares
147.10M
Prev Year: 145.90M
YoY: +0.8%
Net Interest Income
-
Diluted EPS Excluding ExtraOrd Items
8.789
Prev Year: 11.187
YoY: -21.4%
EBIT
-
Diluted Normalized EPS
13.735
Prev Year: 12.052
YoY: +14.0%
EBITDA
-
Unusual Expense (Income)
779.70M
Prev Year: 147.40M
YoY: +429.0%
Reconciled Cost of Revenue
-
Values in USD

Biogen key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$9.9B$9.7B$9.8B$10.2B$11.0B
Gross profit$7.5B$7.5B$7.4B$8.2B$8.9B
Operating income$1.7B$2.2B$1.6B$4.1B$2.8B
Net income$1.3B$1.6B$1.2B$3.0B$1.6B
Diluted EPS––––$10.40
Total assets$29.4B$28.0B$26.8B$24.6B$23.9B
Total liabilities$11.2B$11.3B$12.0B$11.2B$12.9B
Shareholders' equity$18.3B$16.7B$14.8B$13.4B$10.9B
Cash––––$2.3B
Total debt$6.3B$6.3B$6.9B$6.3B$7.6B
Operating cash flow$2.2B$2.9B$1.5B$1.4B$3.6B
Capital spending––––$294.9M
Free cash flow––––$3.3B

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2020.

Questions and answers

What was Biogen's revenue in fiscal year 2025?

$9.89 billion, up 2.2% from $9.68 billion in fiscal year 2024.

How much profit does Biogen make?

Biogen reported net income of $1.29 billion for fiscal year 2025 (13.1% of revenue); operating income was $1.72 billion.

How much cash and debt does Biogen have?

At the end of fiscal year 2025: total debt of $6.29 billion.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube